Regulation 137 Amendment of regulation 171 (exempt advanced therapy medicinal products)I1
United Kingdom
In regulation 171(2)(c) for “Regulation (EC) No 726/2004 F1substitute—
“—
(i)in the case of a product for sale or supply in Northern Ireland, Regulation (EC) No 726/2004, and
(ii)in the case of a product for sale or supply in Great Britain, regulation 49(1).”
Annotations
Textual amendments
- F1
Words in reg. 137 substituted (31.12.2020 immediately before IP completion day) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 105
Commencement
- I1
Reg. 137 in force at 31.12.2020 on IP completion day (in accordance with 2020 c. 1, Sch. 5 para. 1(1)), see reg. 1